KOREA WHO

Yoon Tae-young is the CEO of Protinah.

He is focusing on entering the U.S. market and securing a stable revenue base through an independent diagnostic service model.

He was born on February 5, 1976.

He majored in Electrical, Electronic, and Control Engineering at Seoul National University, where he later earned both his master’s and doctoral degrees in Electrical Engineering.

He worked as a researcher at the Inter-University Semiconductor Research Center at Seoul National University, and as a postdoctoral researcher at the Department of Physics at the University of Illinois and the Howard Hughes Medical Institute in the United States. He later joined KAIST (Korea Advanced Institute of Science and Technology) as a tenured professor in the Department of Physics.

In 2015, he founded Protinah, a big data company that analyzes in vivo protein interactions used throughout the entire new drug development process.

Afterwards, he moved to Yonsei University and was later appointed as a professor in the Department of Biological Sciences at Seoul National University.

He has also served as Director of the Creative Research Initiative Program of the National Research Foundation of Korea, Principal Investigator for the Physics Division of the Basic Science Program at the Samsung Science & Technology Foundation, and a civilian member of the Bio Special Committee of the National Science and Technology Advisory Council.

He is recognized for his strong research capability and practical execution skills.

#Protinah #YoonTaeYoung #SeoulNationalUniversity #KAIST #YonseiUniversity #biotech #proteomics #newdrugdevelopment #bigdata #lifescience